Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Autor: Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B

Publikováno v: ClinicoEconomics and Outcomes Research, Vol 2014, Iss default, Pp 389-399 (2014)

Jeffrey J Ellis,1 Alesia B Sadosky,2 Laura L Ten Eyck,1 Joseph C Cappelleri,2 Courtney R Brown,3 Brandon T Suehs,1 Bruce Parsons2 1Comprehensive Health Insights Inc., Louisville, KY, USA; 2Pfizer Inc., New York, NY, USA; 3Humana Inc., Louisville, KY,

Externí odkaz: https://doaj.org/article/b2827c8855424f60bb1f5dce6f5800c4

A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.

Autor: Ellis JJ; Comprehensive Health Insights Inc., 325 West Main Street WFP6W, Louisville, KY, 40202, USA. jellis21@humana.com., Sadosky AB; Pfizer Inc., 235 East 42nd Street, NewYork, NY, 10017, USA. Alesia.Sadosky@pfizer.com., Ten Eyck LL; Formerly of Comprehensive Health Insights Inc., 325 West Main Street WFP6W, Louisville, KY, 40202, USA. lten_eyck@humana.com., Mudumby P; Comprehensive Health Insights Inc., 325 West Main Street WFP6W, Louisville, KY, 40202, USA. pmudumby@humana.com., Cappelleri JC; Pfizer Inc., 235 East 42nd Street, NewYork, NY, 10017, USA. joseph.c.cappelleri@pfizer.com., Ndehi L; Humana Inc., 323 West Main Street WFP-05C, Louisville, KY, 40202, USA. lndehi@humana.com., Suehs BT; Comprehensive Health Insights Inc., 325 West Main Street WFP6W, Louisville, KY, 40202, USA. bsuehs6@humana.com., Parsons B; Pfizer Inc., 235 East 42nd Street, NewYork, NY, 10017, USA. Bruce.Parsons@pfizer.com.

Publikováno v: BMC health services research [BMC Health Serv Res] 2015 Apr 15; Vol. 15, pp. 159. Date of Electronic Publication: 2015 Apr 15.